Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition.

MLA

Allen, Naomi E., et al. “Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition.” Cancer Epidemiology, Biomarkers & Prevention, vol. 16, no. 6, June 2007, pp. 1121–27. EBSCOhost, https://doi.org/10.1158/1055-9965.EPI-06-1062.

APA

Allen, N. E., Key, T. J., Appleby, P. N., Travis, R. C., Roddam, A. W., Rinaldi, S., Egevad, L., Rohrmann, S., Linseisen, J., Pischon, T., Boeing, H., Johnsen, N. F., Tjønneland, A., Grønbæk, H., Overvad, K., Kiemeney, L., Bueno-de-Mesquita, H. B., Bingham, S., Kay Tee Khaw, & Tumino, R. (2007). Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiology, Biomarkers & Prevention, 16(6), 1121–1127. https://doi.org/10.1158/1055-9965.EPI-06-1062

Chicago

Allen, Naomi E., Timothy J. Key, Paul N. Appleby, Ruth C. Travis, Andrew W. Roddam, Sabina Rinaldi, Lars Egevad, et al. 2007. “Serum Insulin-like Growth Factor (IGF)-I and IGF-Binding Protein-3 Concentrations and Prostate Cancer Risk: Results from the European Prospective Investigation into Cancer and Nutrition.” Cancer Epidemiology, Biomarkers & Prevention 16 (6): 1121–27. doi:10.1158/1055-9965.EPI-06-1062.